Improved glycaemic control and treatment satisfaction with a simple wearable 3-day insulin delivery device among people with Type 2 diabetes.

Julia K Mader Leslie C Lilly Felix AbererT PoettlerD JohnsM TrautmannJ L WarnerT R Pieber

Published in: Diabetic medicine : a journal of the British Diabetic Association (2018)

Adults with Type 2 diabetes were safely transitioned from insulin injections to the PAQ and had significantly improved glycaemic control and treatment satisfaction with insulin therapy. (ClinicalTrials.gov identifiers: NCT02158078 & NCT02419859).

Keyphrases

type diabetes
glycemic control
stem cells
blood pressure
adipose tissue
skeletal muscle
smoking cessation
replacement therapy
weight loss